| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.27 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |